-
1
-
-
84934287610
-
Therapeutic potential and challenges of natural killer cells in treatment of solid tumors
-
Gras Navarro A, Björklund AT and Chekenya M: Therapeutic potential and challenges of natural killer cells in treatment of solid tumors. Front Immunol 6: 202, 2015.
-
(2015)
Front Immunol
, vol.6
, pp. 202
-
-
Gras Navarro, A.1
Björklund, A.T.2
Chekenya, M.3
-
2
-
-
84925222119
-
Nivolumab in previously untreated melanoma without
-
Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, et al: Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372: 320-330, 2015.
-
(2015)
BRAF Mutation. N Engl J Med
, vol.372
, pp. 320-330
-
-
Robert, C.1
Long, G.V.2
Brady, B.3
Dutriaux, C.4
Maio, M.5
Mortier, L.6
Hassel, J.C.7
Rutkowski, P.8
McNeil, C.9
Kalinka-Warzocha, E.10
-
3
-
-
84936791837
-
Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer
-
Brahmer J, Reckamp KL, Baas P, Crinò L, Eberhardt WE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E, et al: Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 373: 123-135, 2015.
-
(2015)
N Engl J Med
, vol.373
, pp. 123-135
-
-
Brahmer, J.1
Reckamp, K.L.2
Baas, P.3
Crinò, L.4
Eberhardt, W.E.5
Poddubskaya, E.6
Antonia, S.7
Pluzanski, A.8
Vokes, E.E.9
Holgado, E.10
-
4
-
-
0033618504
-
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
-
Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL and Spies T: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729, 1999.
-
(1999)
Science
, vol.285
, pp. 727-729
-
-
Bauer, S.1
Groh, V.2
Wu, J.3
Steinle, A.4
Phillips, J.H.5
Lanier, L.L.6
Spies, T.7
-
5
-
-
68849105814
-
Oncogenic stress sensed by the immune system: Role of natural killer cell receptors
-
Raulet DH and Guerra N: Oncogenic stress sensed by the immune system: Role of natural killer cell receptors. Nat Rev Immunol 9: 568-580, 2009.
-
(2009)
Nat Rev Immunol
, vol.9
, pp. 568-580
-
-
Raulet, D.H.1
Guerra, N.2
-
6
-
-
84961879643
-
NKG2D receptor and its ligands in host defense
-
Lanier LL: NKG2D receptor and its ligands in host defense. Cancer Immunol Res 3: 575-582, 2015.
-
(2015)
Cancer Immunol Res
, vol.3
, pp. 575-582
-
-
Lanier, L.L.1
-
7
-
-
24144443517
-
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
-
Gasser S, Orsulic S, Brown EJ and Raulet DH: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190, 2005.
-
(2005)
Nature
, vol.436
, pp. 1186-1190
-
-
Gasser, S.1
Orsulic, S.2
Brown, E.J.3
Raulet, D.H.4
-
8
-
-
77956911325
-
Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missingself recognition
-
Fine JH, Chen P, Mesci A, Allan DS, Gasser S, Raulet DH and Carlyle JR: Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missingself recognition. Cancer Res 70: 7102-7113, 2010.
-
(2010)
Cancer Res
, vol.70
, pp. 7102-7113
-
-
Fine, J.H.1
Chen, P.2
Mesci, A.3
Allan, D.S.4
Gasser, S.5
Raulet, D.H.6
Carlyle, J.R.7
-
9
-
-
65349131915
-
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
-
Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, Di Gialleonardo V, Cippitelli M, Fionda C, Petrucci MT, Guarini A, et al: ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113: 3503-3511, 2009.
-
(2009)
Blood
, vol.113
, pp. 3503-3511
-
-
Soriani, A.1
Zingoni, A.2
Cerboni, C.3
Iannitto, M.L.4
Ricciardi, M.R.5
Di Gialleonardo, V.6
Cippitelli, M.7
Fionda, C.8
Petrucci, M.T.9
Guarini, A.10
-
10
-
-
84898035920
-
DNA double-strand break repair in a cellular context
-
Shibata A and Jeggo PA: DNA double-strand break repair in a cellular context. Clin Oncol 26: 243-249, 2014.
-
(2014)
Clin Oncol
, vol.26
, pp. 243-249
-
-
Shibata, A.1
Jeggo, P.A.2
-
11
-
-
0037365789
-
ATM and related protein kinases: Safeguarding genome integrity
-
Shiloh Y: ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 3: 155-168, 2003.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 155-168
-
-
Shiloh, Y.1
-
12
-
-
62549156232
-
Changing of the guard: How ATM hands off DNA double-strand break signaling to ATR
-
Rhind N: Changing of the guard: How ATM hands off DNA double-strand break signaling to ATR. Mol Cell 33: 672-674, 2009.
-
(2009)
Mol Cell
, vol.33
, pp. 672-674
-
-
Rhind, N.1
-
13
-
-
79955460159
-
H3K9 methyltransferase G9a and the related molecule GLP
-
Shinkai Y and Tachibana M: H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 25: 781-788, 2011.
-
(2011)
Genes Dev
, vol.25
, pp. 781-788
-
-
Shinkai, Y.1
Tachibana, M.2
-
14
-
-
0034056777
-
Structure-function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression
-
Melcher M, Schmid M, Aagaard L, Selenko P, Laible G and Jenuwein T: Structure-function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression. Mol Cell Biol 20: 3728-3741, 2000.
-
(2000)
Mol Cell Biol
, vol.20
, pp. 3728-3741
-
-
Melcher, M.1
Schmid, M.2
Aagaard, L.3
Selenko, P.4
Laible, G.5
Jenuwein, T.6
-
15
-
-
0035816682
-
Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3
-
Tachibana M, Sugimoto K, Fukushima T and Shinkai Y: Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem 276: 25309-25317, 2001.
-
(2001)
J Biol Chem
, vol.276
, pp. 25309-25317
-
-
Tachibana, M.1
Sugimoto, K.2
Fukushima, T.3
Shinkai, Y.4
-
16
-
-
47249144117
-
Human tumor-derived exosomes down-modulate NKG2D expression
-
Clayton A, Mitchell JP, Court J, Linnane S, Mason MD and Tabi Z: Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol 180: 7249-7258, 2008.
-
(2008)
J Immunol
, vol.180
, pp. 7249-7258
-
-
Clayton, A.1
Mitchell, J.P.2
Court, J.3
Linnane, S.4
Mason, M.D.5
Tabi, Z.6
-
17
-
-
84892369333
-
DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities
-
Shibata A, Moiani D, Arvai AS, Perry J, Harding SM, Genois MM, Maity R, van Rossum-Fikkert S, Kertokalio A, Romoli F, et al: DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities. Mol Cell 53: 7-18, 2014.
-
(2014)
Mol Cell
, vol.53
, pp. 7-18
-
-
Shibata, A.1
Moiani, D.2
Arvai, A.S.3
Perry, J.4
Harding, S.M.5
Genois, M.M.6
Maity, R.7
Van Rossum-Fikkert, S.8
Kertokalio, A.9
Romoli, F.10
-
18
-
-
84926347357
-
Pre-exposure to ionizing radiation stimulates DNA double strand break end resection, promoting the use of homologous recombination repair
-
Nakajima NI, Hagiwara Y, Oike T, Okayasu R, Murakami T, Nakano T and Shibata A: Pre-exposure to ionizing radiation stimulates DNA double strand break end resection, promoting the use of homologous recombination repair. PLoS One 10: e0122582, 2015.
-
(2015)
PLoS One
, vol.10
, pp. e0122582
-
-
Nakajima, N.I.1
Hagiwara, Y.2
Oike, T.3
Okayasu, R.4
Murakami, T.5
Nakano, T.6
Shibata, A.7
-
19
-
-
0033536068
-
Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB
-
Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH and Spies T: Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 96: 6879-6884, 1999.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 6879-6884
-
-
Groh, V.1
Rhinehart, R.2
Secrist, H.3
Bauer, S.4
Grabstein, K.H.5
Spies, T.6
-
20
-
-
0034895155
-
Strategies for target cell recognition by natural killer cells
-
Diefenbach A and Raulet DH: Strategies for target cell recognition by natural killer cells. Immunol Rev 181: 170-184, 2001.
-
(2001)
Immunol Rev
, vol.181
, pp. 170-184
-
-
Diefenbach, A.1
Raulet, D.H.2
-
21
-
-
0036829733
-
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: Analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity
-
Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, et al: Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: Analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 62: 6178-6186, 2002.
-
(2002)
Cancer Res
, vol.62
, pp. 6178-6186
-
-
Pende, D.1
Rivera, P.2
Marcenaro, S.3
Chang, C.C.4
Biassoni, R.5
Conte, R.6
Kubin, M.7
Cosman, D.8
Ferrone, S.9
Moretta, L.10
-
22
-
-
79960812015
-
Understanding the limitations of radiation-induced cell cycle checkpoints
-
Deckbar D, Jeggo PA and Löbrich M: Understanding the limitations of radiation-induced cell cycle checkpoints. Crit Rev Biochem Mol Biol 46: 271-283, 2011.
-
(2011)
Crit Rev Biochem Mol Biol
, vol.46
, pp. 271-283
-
-
Deckbar, D.1
Jeggo, P.A.2
Löbrich, M.3
-
23
-
-
79952762235
-
Factors determining DNA double-strand break repair pathway choice in G2 phase
-
Shibata A, Conrad S, Birraux J, Geuting V, Barton O, Ismail A, Kakarougkas A, Meek K, Taucher-Scholz G, Löbrich M, et al: Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO J 30: 1079-1092, 2011.
-
(2011)
EMBO J
, vol.30
, pp. 1079-1092
-
-
Shibata, A.1
Conrad, S.2
Birraux, J.3
Geuting, V.4
Barton, O.5
Ismail, A.6
Kakarougkas, A.7
Meek, K.8
Taucher-Scholz, G.9
Löbrich, M.10
-
24
-
-
77955158757
-
Differences in the kinetics of gamma-H2AX fluorescence decay after exposure to low and high LET radiation
-
Schmid TE, Dollinger G, Beisker W, Hable V, Greubel C, Auer S, Mittag A, Tarnok A, Friedl AA, Molls M, et al: Differences in the kinetics of gamma-H2AX fluorescence decay after exposure to low and high LET radiation. Int J Radiat Biol 86: 682-691, 2010.
-
(2010)
Int J Radiat Biol
, vol.86
, pp. 682-691
-
-
Schmid, T.E.1
Dollinger, G.2
Beisker, W.3
Hable, V.4
Greubel, C.5
Auer, S.6
Mittag, A.7
Tarnok, A.8
Friedl, A.A.9
Molls, M.10
-
25
-
-
30344463835
-
ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks
-
Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J and Jackson SP: ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 8: 37-45, 2006.
-
(2006)
Nat Cell Biol
, vol.8
, pp. 37-45
-
-
Jazayeri, A.1
Falck, J.2
Lukas, C.3
Bartek, J.4
Smith, G.C.5
Lukas, J.6
Jackson, S.P.7
-
26
-
-
0042632901
-
Pathways of DNA double-strand break repair during the mammalian cell cycle
-
Rothkamm K, Krüger I, Thompson LH and Löbrich M: Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 23: 5706-5715, 2003.
-
(2003)
Mol Cell Biol
, vol.23
, pp. 5706-5715
-
-
Rothkamm, K.1
Krüger, I.2
Thompson, L.H.3
Löbrich, M.4
-
27
-
-
34548779134
-
Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells
-
Kato N, Tanaka J, Sugita J, Toubai T, Miura Y, Ibata M, Syono Y, Ota S, Kondo T, Asaka M, et al: Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia 21: 2103-2108, 2007.
-
(2007)
Leukemia
, vol.21
, pp. 2103-2108
-
-
Kato, N.1
Tanaka, J.2
Sugita, J.3
Toubai, T.4
Miura, Y.5
Ibata, M.6
Syono, Y.7
Ota, S.8
Kondo, T.9
Asaka, M.10
-
28
-
-
84921614969
-
Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia
-
Baragaño Raneros A, Martín-Palanco V, Fernandez AF, Rodriguez RM, Fraga MF, Lopez-Larrea C and Suarez-Alvarez B: Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia. Genes Immun 16: 71-82, 2015.
-
(2015)
Genes Immun
, vol.16
, pp. 71-82
-
-
Baragaño Raneros, A.1
Martín-Palanco, V.2
Fernandez, A.F.3
Rodriguez, R.M.4
Fraga, M.F.5
Lopez-Larrea, C.6
Suarez-Alvarez, B.7
-
29
-
-
31344466008
-
DNA methylation and gene silencing in cancer
-
Baylin SB: DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2 (Suppl 1): S4-S11, 2005.
-
(2005)
Nat Clin Pract Oncol
, vol.2
, pp. S4-S11
-
-
Baylin, S.B.1
-
30
-
-
28244502269
-
Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B
-
Skov S, Pedersen MT, Andresen L, Straten PT, Woetmann A and Odum N: Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res 65: 11136-11145, 2005.
-
(2005)
Cancer Res
, vol.65
, pp. 11136-11145
-
-
Skov, S.1
Pedersen, M.T.2
Andresen, L.3
Straten, P.T.4
Woetmann, A.5
Odum, N.6
-
31
-
-
22244485707
-
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate
-
Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, et al: Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res 65: 6321-6329, 2005.
-
(2005)
Cancer Res
, vol.65
, pp. 6321-6329
-
-
Armeanu, S.1
Bitzer, M.2
Lauer, U.M.3
Venturelli, S.4
Pathil, A.5
Krusch, M.6
Kaiser, S.7
Jobst, J.8
Smirnow, I.9
Wagner, A.10
-
32
-
-
38949193232
-
NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class i specificities
-
Diermayr S, Himmelreich H, Durovic B, Mathys-Schneeberger A, Siegler U, Langenkamp U, Hofsteenge J, Gratwohl A, Tichelli A, Paluszewska M, et al: NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities. Blood 111: 1428-1436, 2008.
-
(2008)
Blood
, vol.111
, pp. 1428-1436
-
-
Diermayr, S.1
Himmelreich, H.2
Durovic, B.3
Mathys-Schneeberger, A.4
Siegler, U.5
Langenkamp, U.6
Hofsteenge, J.7
Gratwohl, A.8
Tichelli, A.9
Paluszewska, M.10
-
33
-
-
84871915611
-
RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry
-
Jung H, Hsiung B, Pestal K, Procyk E and Raulet DH: RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. J Exp Med 209: 2409-2422, 2012.
-
(2012)
J Exp Med
, vol.209
, pp. 2409-2422
-
-
Jung, H.1
Hsiung, B.2
Pestal, K.3
Procyk, E.4
Raulet, D.H.5
-
34
-
-
36048958965
-
Histone deacetylase inhibitors: Overview and perspectives
-
Dokmanovic M, Clarke C and Marks PA: Histone deacetylase inhibitors: Overview and perspectives. Mol Cancer Res 5: 981-989, 2007.
-
(2007)
Mol Cancer Res
, vol.5
, pp. 981-989
-
-
Dokmanovic, M.1
Clarke, C.2
Marks, P.A.3
-
35
-
-
49849101700
-
Competitive or noncompetitive, that's the question: Research toward histone deacetylase inhibitors
-
Su H, Altucci L and You Q: Competitive or noncompetitive, that's the question: Research toward histone deacetylase inhibitors. Mol Cancer Ther 7: 1007-1012, 2008.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 1007-1012
-
-
Su, H.1
Altucci, L.2
You, Q.3
-
36
-
-
84920840486
-
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid-Short Radiotherapy-Rectum 3rd trial)
-
Avallone A, Piccirillo MC, Delrio P, Pecori B, Di Gennaro E, Aloj L, Tatangelo F, D'Angelo V, Granata C, Cavalcanti E, et al: Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid-short Radiotherapy-rectum 3rd trial). BMC Cancer 14: 875, 2014.
-
(2014)
BMC Cancer
, vol.14
, pp. 875
-
-
Avallone, A.1
Piccirillo, M.C.2
Delrio, P.3
Pecori, B.4
Di Gennaro, E.5
Aloj, L.6
Tatangelo, F.7
D'Angelo, V.8
Granata, C.9
Cavalcanti, E.10
-
37
-
-
84933526775
-
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): A phase 3, double-blind, randomised, placebo-controlled trial
-
Krug LM, Kindler HL, Calvert H, Manegold C, Tsao AS, Fennell D, Öhman R, Plummer R, Eberhardt WE, Fukuoka K, et al: Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): A phase 3, double-blind, randomised, placebo-controlled trial. Lancet Oncol 16: 447-456, 2015.
-
(2015)
Lancet Oncol
, vol.16
, pp. 447-456
-
-
Krug, L.M.1
Kindler, H.L.2
Calvert, H.3
Manegold, C.4
Tsao, A.S.5
Fennell, D.6
Öhman, R.7
Plummer, R.8
Eberhardt, W.E.9
Fukuoka, K.10
-
38
-
-
33747453473
-
Insulators: Exploiting transcriptional and epigenetic mechanisms
-
Gaszner M and Felsenfeld G: Insulators: Exploiting transcriptional and epigenetic mechanisms. Nat Rev Genet 7: 703-713, 2006.
-
(2006)
Nat Rev Genet
, vol.7
, pp. 703-713
-
-
Gaszner, M.1
Felsenfeld, G.2
-
39
-
-
84892942381
-
New and emerging HDAC inhibitors for cancer treatment
-
West AC and Johnstone RW: New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 124: 30-39, 2014.
-
(2014)
J Clin Invest
, vol.124
, pp. 30-39
-
-
West, A.C.1
Johnstone, R.W.2
-
40
-
-
77956341931
-
Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous endjoining
-
Miller KM, Tjeertes JV, Coates J, Legube G, Polo SE, Britton S and Jackson SP: Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous endjoining. Nat Struct Mol Biol 17: 1144-1151, 2010.
-
(2010)
Nat Struct Mol Biol
, vol.17
, pp. 1144-1151
-
-
Miller, K.M.1
Tjeertes, J.V.2
Coates, J.3
Legube, G.4
Polo, S.E.5
Britton, S.6
Jackson, S.P.7
-
41
-
-
84938827689
-
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy
-
Blattmann C, Oertel S, Thiemann M, Dittmar A, Roth E, Kulozik AE, Ehemann V, Weichert W, Huber PE, Stenzinger A, et al: Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy. Radiat Oncol 10: 146, 2015.
-
(2015)
Radiat Oncol
, vol.10
, pp. 146
-
-
Blattmann, C.1
Oertel, S.2
Thiemann, M.3
Dittmar, A.4
Roth, E.5
Kulozik, A.E.6
Ehemann, V.7
Weichert, W.8
Huber, P.E.9
Stenzinger, A.10
-
42
-
-
3042568739
-
Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor
-
Kim JH, Shin JH and Kim IH: Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. Int J Radiat Oncol Biol Phys 59: 1174-1180, 2004.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.59
, pp. 1174-1180
-
-
Kim, J.H.1
Shin, J.H.2
Kim, I.H.3
-
43
-
-
79959862072
-
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates
-
Cornelissen B, Kersemans V, Darbar S, Thompson J, Shah K, Sleeth K, Hill MA and Vallis KA: Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates. Cancer Res 71: 4539-4549, 2011.
-
(2011)
Cancer Res
, vol.71
, pp. 4539-4549
-
-
Cornelissen, B.1
Kersemans, V.2
Darbar, S.3
Thompson, J.4
Shah, K.5
Sleeth, K.6
Hill, M.A.7
Vallis, K.A.8
-
44
-
-
27644586649
-
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity
-
Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL, Ismail S, Stevens C and Meyn RE: Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res 11: 4912-4922, 2005.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4912-4922
-
-
Munshi, A.1
Kurland, J.F.2
Nishikawa, T.3
Tanaka, T.4
Hobbs, M.L.5
Tucker, S.L.6
Ismail, S.7
Stevens, C.8
Meyn, R.E.9
-
45
-
-
84899063851
-
The anticancer effects of HDAC inhibitors require the immune system
-
West AC, Smyth MJ and Johnstone RW: The anticancer effects of HDAC inhibitors require the immune system. Oncoimmunology 3: e27414, 2014.
-
(2014)
Oncoimmunology
, vol.3
, pp. e27414
-
-
West, A.C.1
Smyth, M.J.2
Johnstone, R.W.3
|